Works matching IS 17534658 AND DT 2016 AND VI 10 AND IP 5


Results: 11
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat<sup>®</sup> fixed-dose combination for chronic obstructive pulmonary disease patients in Italy.

    Published in:
    Therapeutic Advances in Respiratory Disease, 2016, v. 10, n. 5, p. 391, doi. 10.1177/1753465816657272
    By:
    • Selya-Hammer, Carl;
    • Gonzalez-Rojas Guix, Nuria;
    • Baldwin, Michael;
    • Ternouth, Andrew;
    • Miravitlles, Marc;
    • Rutten-van Mölken, Maureen;
    • Goosens, Lucas M. A.;
    • Buyukkaramikli, Nasuh;
    • Acciai, Valentina
    Publication type:
    Article